Literature DB >> 9218557

Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles.

S Güldütuna1, B Deisinger, A Weiss, H J Freisleben, G Zimmer, P Sipos, U Leuschner.   

Abstract

Ursodeoxycholate is used to treat primary biliary cirrhosis and is incorporated into hepatocyte plasma membranes. Its steroid nucleus binds to the apolar domain of the membrane, in a similar position to cholesterol. Therefore the question arises whether ursodeoxycholate has a similar effect on membrane structure and stability as cholesterol. Using differential scanning calorimetry the thermotropic behavior of egg phosphatidylcholine and dimyristoylphosphatidylcholine were studied after incubation with cholesterol or ursodeoxycholate. Large unilamellar vesicles were prepared with cholesterol contents of 0-50%. Following incubation of these vesicles with different amounts of ursodeoxycholate, vesicle stability in a gravitational field was investigated by measuring the phospholipid and cholesterol release. Vesicle size was studied by laser light scattering after incubation with cheno- and ursodeoxycholate, and the release of entrapped carboxyfluorescein was measured by means of fluorescence spectroscopy. Increasing cholesterol diminished the enthalpy of the phase transition in the membrane. Ursodeoxycholate decreased the enthalpy of the phase transition at even lower concentrations. Lipid release from vesicles in a high gravitational field diminished with increasing cholesterol content of the vesicles. Ursodeoxycholate had a comparable effect, which increased as the cholesterol content of the vesicles was decreased. Chenodeoxycholate damaged vesicles, whereas ursodeoxycholate did not. Cholesterol and ursodeoxycholate (below its critical micellar concentration) decreased the carboxyfluorescein release from vesicles induced by chenodeoxycholate. Thus like cholesterol, ursodeoxycholate is incorporated into phospholipid model membranes and reduces the change in enthalpy of the gel to liquid-crystalline phase transition. Like cholesterol ursodeoxycholate also maintains membrane stability and prevents membrane damage induced by mechanical and chemical stress.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218557     DOI: 10.1016/s0005-2736(97)00030-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease.

Authors:  J Sinisalo; H Vanhanen; P Pajunen; H Vapaatalo; M S Nieminen
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

2.  Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.

Authors:  M Leuschner; C F Dietrich; T You; C Seidl; J Raedle; G Herrmann; H Ackermann; U Leuschner
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

3.  Alkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activity.

Authors:  Muhammad Suleman; Jean-Pierre Gangneux; Laurent Legentil; Sorya Belaz; Yari Cabezas; Christelle Manuel; Rémy Dureau; Odile Sergent; Agnès Burel; Franck Daligault; Vincent Ferrières; Florence Robert-Gangneux
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

4.  Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages.

Authors:  Shuhei Takano; Yukihiko Aramaki; Seishi Tsuchiya
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.